Parr McKnight Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,550
Closed -$250K 225
2025
Q3
$250K Hold
5,550
0.03% 217
2025
Q2
$257K Buy
5,550
+8
+0.1% +$393 0.04% 212
2025
Q1
$338K Buy
5,542
+3
+0.1% +$175 0.05% 193
2024
Q4
$313K Buy
+5,539
New +$309K 0.04% 198

Other funds holding BMY

Parr McKnight Wealth Management Group's BMY Position: Q4 2025 in Review

Parr McKnight Wealth Management Group sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 5,550 shares — an estimated $250K sold.

Parr McKnight Wealth Management Group first reported a position in BMY in Q4 2024 and held it in 4 quarters. The position peaked at $338K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Parr McKnight Wealth Management Group reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Parr McKnight Wealth Management Group sold 5,550 Bristol-Myers Squibb shares in Q4 2025, an estimated $250K.
  • Parr McKnight Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 4 quarters.
  • Parr McKnight Wealth Management Group's Bristol-Myers Squibb position peaked at $338K in Q1 2025.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Parr McKnight Wealth Management Group's 13F filing for Q4 2025, filed 10 Feb 2026.